Thesis, the First High Quality and Customized Nootropics Solution, Raises Total of $13.5 Million in Funding
Previously the company raised $5.1 million in an undisclosed seed round that included Unilever Ventures, MBX, Trust Ventures and Redo Ventures.
- Previously the company raised $5.1 million in an undisclosed seed round that included Unilever Ventures, MBX, Trust Ventures and Redo Ventures.
- View the full release here: https://www.businesswire.com/news/home/20230502005870/en/
Thesis recognizes that nootropics are not a one-size-fits-all wellness category. - Through the highest quality ingredients and a customized approach, the brand helps people effectively boost their cognition & productivity.
- The new capital will support Thesis as it makes key executive hires, expands out its product selection and undergoes clinical trials.